NASDAQ:INMD InMode (INMD) Stock Price, News & Analysis $14.53 -0.40 (-2.68%) Closing price 04:00 PM EasternExtended Trading$14.58 +0.06 (+0.38%) As of 07:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About InMode Stock (NASDAQ:INMD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get InMode alerts:Sign Up Key Stats Today's Range$14.52▼$14.9350-Day Range$13.28▼$15.3652-Week Range$13.14▼$19.85Volume616,750 shsAverage Volume1.65 million shsMarket Capitalization$918.44 millionP/E Ratio6.24Dividend YieldN/APrice Target$18.54Consensus RatingHold Company Overview InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel. Read More InMode Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks78th Percentile Overall ScoreINMD MarketRank™: InMode scored higher than 78% of companies evaluated by MarketBeat, and ranked 346th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.1 / 5Analyst RatingHold Consensus RatingInMode has received a consensus rating of Hold. The company's average rating score is 2.13, and is based on 1 buy rating, 7 hold ratings, and no sell ratings.Amount of Analyst CoverageInMode has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about InMode's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth4.00% Earnings GrowthEarnings for InMode are expected to grow by 4.00% in the coming year, from $1.75 to $1.82 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of InMode is 6.24, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.77.Price to Earnings Ratio vs. SectorThe P/E ratio of InMode is 6.24, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.90.Price to Book Value per Share RatioInMode has a P/B Ratio of 1.44. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about InMode's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted6.42% of the float of InMode has been sold short.Short Interest Ratio / Days to CoverInMode has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in InMode has recently decreased by 30.26%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldInMode does not currently pay a dividend.Dividend GrowthInMode does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted6.42% of the float of InMode has been sold short.Short Interest Ratio / Days to CoverInMode has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in InMode has recently decreased by 30.26%, indicating that investor sentiment is improving significantly. News and Social Media2.1 / 5News Sentiment0.82 News SentimentInMode has a news sentiment score of 0.82. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.63 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for InMode this week, compared to 5 articles on an average week.Search InterestOnly 5 people have searched for INMD on MarketBeat in the last 30 days. This is a decrease of -29% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, InMode insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 6.92% of the stock of InMode is held by insiders.Percentage Held by Institutions68.04% of the stock of InMode is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about InMode's insider trading history. Receive INMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InMode and its competitors with MarketBeat's FREE daily newsletter. Email Address INMD Stock News HeadlinesCanaccord Genuity Maintains a Hold Rating on InMode Ltd. (INMD)July 16, 2025 | insidermonkey.comAnalysts Set InMode Ltd. (NASDAQ:INMD) PT at $18.54July 15, 2025 | americanbankingnews.comI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before the open. That’s the kind of move Tim Sykes built his XGPT system to trade. It scans AI news in real time, filters the noise, and pinpoints when to strike. He’s now showing exactly how it works — before the next headline hits.July 24 at 2:00 AM | Timothy Sykes (Ad)InMode's (INMD) "Hold" Rating Reiterated at Canaccord Genuity GroupJuly 14, 2025 | americanbankingnews.comInMode: Margin Pressure, But Optionality Makes It Worth A LookJuly 12, 2025 | seekingalpha.comInMode to report Q2 results on July 30, sees revenue of about $95.5MJuly 10, 2025 | msn.comInMode to Report Second Quarter 2025 Financial Results and Hold Conference Call on July 30, Expects Q2 Revenue Between $95.4M-$95.5M, Decreases Full Year 2025 Revenue Guidance to be Between $365M-$375MJuly 10, 2025 | prnewswire.comPositive earnings growth hasn't been enough to get InMode (NASDAQ:INMD) shareholders a favorable return over the last three yearsJuly 5, 2025 | finance.yahoo.comSee More Headlines INMD Stock Analysis - Frequently Asked Questions How have INMD shares performed this year? InMode's stock was trading at $16.70 at the beginning of the year. Since then, INMD shares have decreased by 13.0% and is now trading at $14.53. How were InMode's earnings last quarter? InMode Ltd. (NASDAQ:INMD) released its quarterly earnings results on Monday, April, 28th. The healthcare company reported $0.31 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.45 by $0.14. The firm's revenue was down 3.0% on a year-over-year basis. Read the conference call transcript. When did InMode's stock split? Shares of InMode split before market open on Thursday, September 30th 2021.The 2-1 split was announced on Friday, September 17th 2021. The newly minted shares were distributed to shareholders after the closing bell on Monday, September 27th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. Does InMode have any subsidiaries? The following companies are subsidiaries of InMode: Guangzhou InMode Medical Technology Ltd., InMode Asia Limited., InMode India Private Limited, InMode Japan KK, InMode M.D. Ltd., Invasix Corp., Invasix Iberia S.L., Invasix Inc., and Invasix UK Ltd.. When did InMode IPO? InMode (INMD) raised $75 million in an initial public offering on Thursday, August 8th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Barclays, UBS Investment Bank and Canaccord Genuity acted as the underwriters for the IPO and Baird was co-manager. Who are InMode's major shareholders? Top institutional investors of InMode include Meitav Investment House Ltd. (2.09%), Taylor Frigon Capital Management LLC (0.15%), KLP Kapitalforvaltning AS (0.08%) and Public Employees Retirement System of Ohio (0.03%). How do I buy shares of InMode? Shares of INMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of InMode own? Based on aggregate information from My MarketBeat watchlists, some other companies that InMode investors own include Symbotic (SYM), JPMorgan Nasdaq Equity Premium Income ETF (JEPQ), Voya Infrastructure, Industrials and Materials Fund (IDE), Voyager Therapeutics (VYGR), Humana (HUM), American Water Works (AWK) and Waste Connections (WCN). Company Calendar Last Earnings4/28/2025Today7/24/2025Next Earnings (Estimated)7/30/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED PRODUCTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:INMD CIK1742692 Webwww.inmodemd.com Phone972-4909-7470FaxN/AEmployees480Year Founded2008Price Target and Rating Average Price Target for InMode$18.54 High Price Target$25.00 Low Price Target$15.00 Potential Upside/Downside+27.6%Consensus RatingHold Rating Score (0-4)2.13 Research Coverage8 Analysts Profitability EPS (Trailing Twelve Months)$2.33 Trailing P/E Ratio6.24 Forward P/E Ratio8.30 P/E GrowthN/ANet Income$181.27 million Net Margins44.79% Pretax Margin35.64% Return on Equity17.17% Return on Assets15.20% Debt Debt-to-Equity RatioN/A Current Ratio8.73 Quick Ratio7.86 Sales & Book Value Annual Sales$392.41 million Price / Sales2.34 Cash Flow$1.84 per share Price / Cash Flow7.90 Book Value$10.12 per share Price / Book1.44Miscellaneous Outstanding Shares63,209,000Free Float58,835,000Market Cap$918.43 million OptionableOptionable Beta1.95 Social Links 7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free Report This page (NASDAQ:INMD) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersElon Just Fired the IRS Agents Targeting Your SavingsElon Musk just fired 6,700 IRS agents — and exposed a war on your retirement. While D.C. scrambles to regai...Priority Gold | SponsoredWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredTrump’s Endgame? (R.I.P. China)Tucked inside a Silicon Valley factory, a bold new tech is quietly emerging—one that could ignite a $12 trilli...Brownstone Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | SponsoredBitcoin Beats Gold — But This Coin Could Beat Them BothBitcoin just hit a record high—but it’s not the top crypto play right now. Crypto analyst Juan Villaverde, ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMode Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share InMode With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.